Simplex Trading
TEVA icon

Simplex Trading’s Teva Pharmaceuticals TEVA Stock Holding History

Simplex Trading’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.91M Buy
174,409
+163,094
+1,441% +$5.43M ﹤0.01% 1093
2026
Q1 		$341K Buy
+11,315
New +$364K ﹤0.01% 3681
2025
Q4 		– Sell
-235,083
Closed -$4.75M – 10046
2025
Q3 		$4.75M Buy
235,083
+42,093
+22% +$739K ﹤0.01% 1506
2025
Q2 		$3.23M Sell
192,990
-223,773
-54% -$3.61M ﹤0.01% 1703
2025
Q1 		$6.41M Buy
+416,763
New +$7.44M ﹤0.01% 1152
2024
Q4 		– Sell
-57,994
Closed -$1.06M – 9613
2024
Q3 		$1.04M Sell
57,994
-238,474
-80% -$4.17M ﹤0.01% 2872
2024
Q2 		$4.82M Sell
296,468
-361,219
-55% -$5.56M ﹤0.01% 1461
2024
Q1 		$9.28M Buy
657,687
+10,607
+2% +$134K 0.01% 1171
2023
Q4 		$6.75M Buy
647,080
+13,103
+2% +$122K ﹤0.01% 1346
2023
Q3 		$6.47M Sell
633,977
-427,564
-40% -$3.98M 0.01% 1175
2023
Q2 		$7.99M Buy
1,061,541
+22,734
+2% +$184K 0.01% 1030
2023
Q1 		$9.19M Sell
1,038,807
-235,311
-18% -$2.33M 0.01% 951
2022
Q4 		$11.6M Buy
1,274,118
+230,786
+22% +$2.01M 0.01% 783
2022
Q3 		$8.42M Sell
1,043,332
-362,225
-26% -$3.2M 0.01% 877
2022
Q2 		$10.6M Buy
1,405,557
+336,675
+31% +$2.93M 0.01% 776
2022
Q1 		$10M Buy
1,068,882
+537,557
+101% +$4.49M 0.01% 840
2021
Q4 		$4.25M Buy
531,325
+356,602
+204% +$3.22M ﹤0.01% 1333
2021
Q3 		$1.73M Hold
174,723
– – ﹤0.01% 2347
2021
Q2 		$1.73M Sell
174,723
-19,172
-10% -$203K ﹤0.01% 2356
2021
Q1 		$2.24M Buy
193,895
+71,808
+59% +$823K ﹤0.01% 1490
2020
Q4 		$1.18M Sell
122,087
-67,347
-36% -$645K ﹤0.01% 2345
2020
Q3 		$1.71M Buy
189,434
+87,259
+85% +$923K ﹤0.01% 1681
2020
Q2 		$1.26M Sell
102,175
-146,352
-59% -$1.66M ﹤0.01% 1931
2020
Q1 		$2.23M Buy
+248,527
New +$2.55M ﹤0.01% 1203
2019
Q4 		– Sell
-180,136
Closed -$1.61M – 7962
2019
Q3 		$1.24M Buy
180,136
+39,344
+28% +$301K ﹤0.01% 1741
2019
Q2 		$1.3M Buy
+140,792
New +$1.7M ﹤0.01% 1670
2018
Q4 		– Sell
-71,021
Closed -$1.46M – 7803
2018
Q3 		$1.53M Buy
+71,021
New +$1.65M ﹤0.01% 1476
2018
Q2 		– Sell
-103,831
Closed -$2.12M – 7882
2018
Q1 		$1.77M Buy
+103,831
New +$2.03M 0.08% 216
2017
Q4 		– Sell
-240,285
Closed -$3.61M – 6667
2017
Q3 		$4.23M Buy
240,285
+198,965
+482% +$4.48M 0.17% 101
2017
Q2 		$1.37M Sell
41,320
-88,622
-68% -$2.74M 0.06% 267
2017
Q1 		$4.17M Buy
129,942
+55,381
+74% +$1.89M 0.18% 105
2016
Q4 		$2.7M Sell
74,561
-58,392
-44% -$2.33M 0.16% 107
2016
Q3 		$6.12M Buy
132,953
+128,295
+2,754% +$6.69M 0.41% 30
2016
Q2 		$233K Sell
4,658
-31,626
-87% -$1.68M 0.02% 908
2016
Q1 		$1.94M Buy
+36,284
New +$2.13M 0.15% 120
2015
Q4 		– Sell
-52,467
Closed -$3.24M – 6122
2015
Q3 		$2.96M Buy
52,467
+25,244
+93% +$1.64M 0.22% 83
2015
Q2 		$1.61M Buy
+27,223
New +$1.68M 0.13% 130
2015
Q1 		– Sell
-36,656
Closed -$2.13M – 5577
2014
Q4 		$2.11M Buy
+36,656
New +$2.04M 0.26% 72

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Simplex Trading's TEVA Position: Q2 2026 in Review

Simplex Trading increased its Teva Pharmaceuticals (TEVA) stake by 1,441% in Q2 2026, buying an estimated $5.43M and bringing the position to 174,409 shares worth $5.91M. The position accounts for ﹤0.01% of the portfolio, ranked #1093.

Simplex Trading first reported a position in TEVA in Q4 2014 and has held it in 38 quarters since. The position peaked at $11.6M in Q4 2022. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Simplex Trading held 174,409 shares of Teva Pharmaceuticals worth $5.91M as of Q2 2026.
  • Simplex Trading bought 163,094 Teva Pharmaceuticals shares in Q2 2026, an estimated $5.43M.
  • Teva Pharmaceuticals made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #1093 holding.
  • Simplex Trading first reported a position in Teva Pharmaceuticals in Q4 2014 and has held it in 38 quarters since.
  • Simplex Trading's Teva Pharmaceuticals position peaked at $11.6M in Q4 2022.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.